Recruiting Chronic Urticaria Studies in Glenview
About Chronic Urticaria Clinical Trials in Glenview
Chronic urticaria involves recurring episodes of itchy, red welts (hives) lasting more than six weeks. Chronic spontaneous urticaria (CSU) occurs without an identifiable trigger. Treatment includes antihistamines and biologics like omalizumab.
There are currently 2 chronic urticaria clinical trials recruiting participants in Glenview, IL. These studies are seeking a combined 86 participants. Research is being sponsored by Novartis Pharmaceuticals, ARS Pharmaceuticals, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Chronic Urticaria Clinical Trials in Glenview — FAQ
Are there chronic urticaria clinical trials in Glenview?
Yes, there are 2 chronic urticaria clinical trials currently recruiting in Glenview, IL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Glenview?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Glenview research site will contact you about next steps.
Are clinical trials in Glenview free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Glenview studies also compensate for your time and travel.
What chronic urticaria treatments are being tested?
The 2 active trials in Glenview are testing new therapies including novel drugs, biologics, and treatment approaches for chronic urticaria.
Data updated July 22, 2026 from ClinicalTrials.gov